对II期单臂瘤学试验的自适应序列设计:西蒙设计的扩展
1Biostatistics, Innovatio Statistics, Inc, Bridgewater, New Jersey, USA.
Journal of biopharmaceutical statistics
|April 15, 2024
概括
适应性瘤学试验设计可以提高功率. 将西蒙的设计扩展到样本大小重新估计 (SSR) 提高了二期试验的统计能力,确保更可靠的疗效评估.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 单臂II期试验在瘤学中至关重要,但在固定样本大小的情况下可能缺乏动力.
- 西蒙的设计是一种广泛使用的固定样本大小方法,在效率低时将样本大小最小化.
研究的目的:
- 根据西蒙的设计,提出一个自适应的序列设计.
- 使用样本大小重新估计 (SSR) 来增强西蒙设计的力量.
主要方法:
- 识别西蒙的试验作为一个组序列设计.
- 应用已建立的样本大小重新估计 (SSR) 方法.
- 开发包含SSR的扩展适应性设计.
主要成果:
- 模拟表明,对西蒙设计的基本SSR添加可能无法足够增加功率.
- 拟议的扩展适应性设计与SSR证明了功率的提高.
结论:
- 适应性设计,特别是用SSR扩展的西蒙设计,为II期瘤学试验提供了增强的功率.
- 与传统的固定样本方法相比,这些先进的设计提供了更强大的疗效评估.
相关概念视频
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Crossover Experiments
4.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.8K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K
Bioavailability Study Design: Single Versus Multiple Dose Studies
352
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
352
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
395
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
395


